Last updated: January 23, 2025
Sponsor: Salem Anaesthesia Pain Clinic
Overall Status: Active - Recruiting
Phase
N/A
Condition
Metabolic Disorders
Treatment
Magnesium
Clinical Study ID
NCT05862454
SalemAnes2022 Mg Steroid Avoid
Ages 20-99 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
adult chronic pain patients
previous interventional injection therapy
consent for interventional injection therapy
good treatment compliance
regular sleep diary
regular pain diary
informed consent for diary review
consent for clinical record quality assurance review
Exclusion
Exclusion Criteria:
organ insufficiency
cognitive disorder
inability to provide consent
major neuropsychiatric disorder
unreliable diary
poor treatment compliance
previous adverse/allergic reactions to magnesium
Study Design
Total Participants: 150
Treatment Group(s): 1
Primary Treatment: Magnesium
Phase:
Study Start date:
July 02, 2020
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
Salem Anaesthesia Pain Clinic
Surrey, British Columbia V3S 7J1
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.